The feminization of HPV: Reversing gender biases in US human papillomavirus vaccine policy
The development of human papillomavirus vaccines, which prevent a range of HPV-related cancers, is a truly impressive scientific achievement. In the decade since approval of the quadrivalent vaccine for the prevention of HPV types 6, 11, 16, and 18, the vaccine has been shown to be highly effective. Recently, a nine-valent vaccine was approved, which protects against five additional oncogenic HPV types, providing increased protection.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063